✦ LIBER ✦

Mutagenic effect of ribavirin in NS5A and NS5B regions and response to inteferon/ribavirin combination therapy in patients with chronic hepatitis C

✍ Scribed by Asahina, Yasuhiro; Izumi, Namiki; Ueda, Ken; Inoue, Kazunari; Nishimura, Yuki; Tsuchiya, Kaoru; Hamano, Kosei; Itakura, Jun; Noguchi, Osamu; Uchihara, Masakatsu; Miyake, Shozo; Enomoto, Nobuyuki; Watanabe, Mamoru

Book ID: 123016052
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 255 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)83926-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutagenic effects of ribavirin and respo

Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C

✍ Yasuhiro Asahina; Namiki Izumi; Nobuyuki Enomoto; Masakatsu Uchihara; Masayuki K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Evolution of hepatitis C virus NS5A regi

Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy

✍ H. J. Yuan; M. Jain; K. K. Snow; M. Gale Jr; W. M. Lee; the HALT-C Trial Group 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

Mutations in the NS5A and E2-PePHD regio

Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin

✍ Sheng-Shun Yang; Ming-Yang Lai; Ding-Shinn Chen; Gran-Hum Chen; Jia-Horng Kao 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Su1067 Drug Resistance Mutations in the

Su1067 Drug Resistance Mutations in the Ns3 and NS5A Regions in Patients With Hepatitis C Virus Genotype 1b and Response to Telaprevir Plus Pegylated-Interferon-Alpha 2B and Ribavirin Combination Therapy

✍ Hayashi, Kazuhiko; Ishigami, Masatoshi; Ishizu, Yoji; Kuzuya, Teiji; Honda, Taka 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Mutations in the core and NS5A region of

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

✍ K. Hayashi; Y. Katano; M. Ishigami; A. Itoh; Y. Hirooka; I. Nakano; F. Urano; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Association of interleukin 28B and mutat

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy

✍ Kazuhiko Hayashi; Yoshiaki Katano; Takashi Honda; Masatoshi Ishigami; Akihiro It 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB